Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders

Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders

US Patent 12208095 · Granted Jan 28, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cereblon ligands and bifunctional compounds comprising the same2025
Compounds and methods for the targeted degradation of androgen receptor2025
Compounds and methods for the targeted degradation of androgen receptor2025
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc bindi2025
Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors2025
Modulators of BCL6 proteolysis and associated methods of use2025
Compounds and methods for the targeted degradation of androgen receptor2025
Compounds and methods for the targeted degradation of androgen receptor2025
Modulators of estrogen receptor proteolysis and associated methods of use2025
Modulators of estrogen receptor proteolysis and associated methods of use2025
Modulators of estrogen receptor proteolysis and associated methods of use2025